CDC42 and breast cancer: As a member of the Rho GTPase family, CDC42 modulates actin dynamics and spinogenesis, and it is also a target of miR-330 in breast cancer and colorectal cancer (Bellot et al., 2014[2]; Jeyapalan et al., 2011[13]).